The move will provide access to the Oxford COVID-19 Vaccine Consortium for production of vaccine should trials prove successful More: Oxford Biomedica bags MHRA nod for two manufacturing suites Source: News
read moreThe drug meets NICE’s criteria to be considered a life-extending treatment More: NICE final guidance backs Pfizer's Lorviqua Source: News
read morePRINCIPLE is looking at whether existing drugs can be repurposed for older patients in the community who show signs of the disease More: Over 50s COVID-19 trial launches across UK Source: News
read moreThousands of patients severely ill with coronavirus are to have their genetic code studied to help uncover whether genetics play a role in susceptibility to the virus. More: New partnership to sequence human genomes in fight against coronavirus Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals